Desminopathy presenting as late onset bilateral facial weakness, with diagnosis supported by lower limb MRI.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
03 2021
Historique:
received: 30 09 2020
revised: 12 12 2020
accepted: 30 12 2020
pubmed: 7 2 2021
medline: 16 11 2021
entrez: 6 2 2021
Statut: ppublish

Résumé

A 63 year old male presented with a 20 year history of facial weakness and several years of nasal regurgitation and dysphonia. Examination revealed bilateral facial weakness with nasal speech. Serum creatine kinase was 918 U/L. Neurophysiological studies suggested a myopathy and biopsy of the left vastus lateralis showed serpentine basophilic inclusions in the sarcoplasm and strong oxidative enzyme activity suggesting mitochondria accumulation. The muscle MRI showed selective fatty replacement within semitendinosus, gastrocnemius and soleus indicative of a desminopathy. A heterozygous missense variant c.17C>G (p.Ser6Trp) was identified within DES, predicted to be pathogenic in silico and previously described in a family with distal limb weakness. There are no previous case reports of desminopathy presenting with facial weakness, to our knowledge. Diagnosis was suggested following myoimaging of clinically unaffected muscles. Our study highlights the importance of muscle MRI in the diagnostic evaluation of muscle disease and further expands the known phenotypic heterogeneity of desminopathies.

Identifiants

pubmed: 33546848
pii: S0960-8966(21)00002-X
doi: 10.1016/j.nmd.2020.12.013
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-252

Informations de copyright

Crown Copyright © 2021. Published by Elsevier B.V. All rights reserved.

Auteurs

Liam S Carroll (LS)

Wessex Neurological Centre, Southampton General Hospital, Southampton SO16 6YD, UK. Electronic address: liamcarroll@nhs.net.

Mark Walker (M)

Wessex Neurological Centre, Southampton General Hospital, Southampton SO16 6YD, UK.

David Allen (D)

Wessex Neurological Centre, Southampton General Hospital, Southampton SO16 6YD, UK.

Ciara Marini-Bettolo (C)

John Walton Muscular Dystrophy Research Centre, Newcastle University and The Newcastle Hospitals NHS Foundation Trust, NE1 3BZ, UK.

Adam Ditchfield (A)

Wessex Neurological Centre, Southampton General Hospital, Southampton SO16 6YD, UK.

Ashwin A Pinto (AA)

Wessex Neurological Centre, Southampton General Hospital, Southampton SO16 6YD, UK.

Simon R Hammans (SR)

Wessex Neurological Centre, Southampton General Hospital, Southampton SO16 6YD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH